— Know what they know.
Not Investment Advice

ANTH OTC

Anthera Pharmaceuticals, Inc.
1W: -0.0% 1M: +0.0% 3M: -90.0% YTD: -0.0% 1Y: +0.0% 3Y: -0.0% 5Y: -99.8%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 54 · $2618 mcap · 26M float · 0.0086% daily turnover

📊 Key Metrics

TTM
$0M
Revenue
+0.0% YoY
$-10M
Net Income
+82.2% YoY
$-32M
Free Cash Flow
+40.1% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-251.4%
ROA-60.9%
ROIC1107.5%

Valuation

P/E-0.0
P/B-0.0
EV/EBITDA0.0

Leverage

Debt/Equity0.00
Current Ratio3.30
Interest Cov.0.0x

Quality Scores

Piotroski F1/9
Altman Z-81.90
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms